Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 296
Selected: 0
NCT IDTitle
NCT02845986Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer
NCT01218594Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer
NCT05543070Low-dose Radiotherapy in iNHL
NCT06078670PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors
NCT07142122Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the Vagus Nerve for Early Upper Gastric Cancer: A Randomized Controlled Clinical Trial
NCT06600841Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer
NCT07257003A Nationwide Multicenter, Single-arm, Retrospective Study of Delayed Endoscopic DTI-BR After Simple Mastectomy
NCT07013461International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
NCT03244904Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment
NCT06553352Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma
NCT06995118The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction
NCT05955391TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)
NCT06538935SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma
NCT04136886Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
NCT05839470Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer
NCT04734249Second-line Surufatinib Combined With Chemotherapy in Advanced CRC
NCT04149015Neoadjuvant POF in the Treatment of Locally Advanced Gastric Cancer
NCT05897138A Study to Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker Analyses
NCT05938309A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors
NCT03731442Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
NCT03273920Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer
NCT05035446Short-term Outcomes of SILS+1 Versus CLS for Distal Gastric Cancer
NCT06095167Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC
NCT06788171PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM
NCT05049811Effects of Mobile Medicine on Cancer Patients
NCT06478472Prospective Clinical Study of Orelabrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local Therapy
NCT06786312A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer
NCT03639415Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain
NCT03380689Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal Cancer
NCT03872635Effects of Anesthesia on Tumor Immunity and Insulin Resistance During Perioperative Period
NCT07154316Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer
NCT06979986SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma
NCT06612814PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer
NCT07001540Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous Transplantation
NCT05461690Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency
NCT06333769Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer
NCT06095154CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma
NCT03116984A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC
NCT03258034A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer
NCT05131243the Role of ctDNA in Predicting the Recurrence Risk of Colorectal Cancer
NCT03222089Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC
NCT04533243Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain
NCT07188584Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer
NCT06242392The Correlation Between HRD Detection and the Efficacy of PARP Inhibitors in Ovarian Cancer
NCT05927844XH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell Carcinoma
NCT05597527Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
NCT04785768IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration
NCT06468670Short-course Radiotherapy Combined With Sintilimab for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
NCT05794841Multi-omics Study of Tongue Coating in Malignant Tumors of Digestive Tract
NCT06787183SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases